Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Another biotechnology company has set its sights on Holly Springs. California-based Genentech plans to create up 420 jobs in Holly Springs — a deal expected to bring an investment of up to $700 ...

San Francisco-based Genentech plans to create up to 420 high-paying jobs in Holly Springs — a project expected to bring an investment of up to $700 million to the southern Wake County town ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

A new biotechnology plant is set to boost North Carolina's economy by more than $3 billion. Medical manufacturing company ...

HOLLY SPRINGS, N.C. (WTVD) -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, North Carolina.

The committee on Monday awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create ...